HN Explorer

mahnen

↗ HN profile [ 63.8 ms ] full profile
Karma
0
Created
()
Submissions
0
  1. Biogen will ask FDA approval for Alzheimer drug candidate after phase3 trial (investors.biogen.com)
    2 points 0